Clinical outcome and determinants of amputation in a large cohort of Iranian patients with diabetic foot ulcers.


Journal

Foot (Edinburgh, Scotland)
ISSN: 1532-2963
Titre abrégé: Foot (Edinb)
Pays: Scotland
ID NLM: 9109564

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 11 07 2019
revised: 05 04 2020
accepted: 14 04 2020
pubmed: 5 10 2020
medline: 7 10 2021
entrez: 4 10 2020
Statut: ppublish

Résumé

Determining the predictive factors of diabetes foot ulcer (DFU) development and lower extremity amputations (LEA) in patients with diabetes mellitus (DM) is of great importance to compose risk stratification models. The aim of this study is to investigate the outcome and predictors of LEA in patients with DFU in large sample of Iranian patients. This prospective cohort study was conducted during a 2-year period from 2014 to 2016, in Shiraz, southern Iran. All the patients with type 1 and 2 DM and DFU were included in the cohort and were followed for 2 years at least. They were visited in the clinic on a monthly basis and development of new DFU and LEA were recorded. The two-year free-DFU survival and predictors of the DFU development and LEA were recorded. Multivariate regression models were used to determine the factors. A total number of 432 patients with mean age of 56.8 ± 13.3 years were included. The two-year DFU-free survival rate was 0.826. The two-year DFU-free survival was associated with male gender (p = 0.005), foot deformity (p = 0.002), history of prior DFU (p < 0.001), cigarette smoking (p = 0.032), nephropathy (p = 0.005), retinopathy (p = 0.007), ischemic heart disease (p = 0.043), and neuropathy (p < 0.001). Development of new DFU is associated with higher age, longer duration of disease, and type I diabetes. LEA was associated with increased white blood cell (WBC), Creatinine and ulcer history for major amputation and ulcer history, fasting blood sugar (FBS), infection, revascularization history, and foot deformity, for minor amputation.

Identifiants

pubmed: 33011496
pii: S0958-2592(20)30026-2
doi: 10.1016/j.foot.2020.101688
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101688

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Mohammad Hadi Niakan (MH)

Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Dehghankhalili (M)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: dehghankhaliliam@gmail.com.

Amirhossein Pourdavood (A)

Clinical Unit of Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran.

Abtin Vahidi (A)

Vascular and Thorax Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Sina Nazemi (S)

Vascular and Thorax Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Ashkan Piranviseh (A)

Vascular and Thorax Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Khatereh Hasanvand (K)

Vascular and Thorax Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH